Identification of CD73 as a Novel Biomarker Encompassing the Tumor Microenvironment, Prognosis, and Therapeutic Responses in Various Cancers
Kun Tang(Central South University), Quan Cheng(Central South University), Wantao Wu(Central South University), Huilan Xu(Central South University), Gelei Xiao(Central South University), Qianrong Wang(Central South University), Nan Zhang(Sichuan University), Zeyu Wang(Anhui University), Xun Zhang(Zaozhuang University), Hao Zhang(Northwestern Polytechnical University), Jingwei Zhang(Sichuan University), Hui Cao(Guangdong Ocean University)
Cited by 22
Related Papers
Glioma targeted therapy: insight into future of molecular approaches
|Molecular Cancer|2022|727
PLGA-based biodegradable microspheres in drug delivery: recent advances in research and application
|Drug Delivery|2021|578
PARP inhibitor resistance: the underlying mechanisms and clinical implications
|Molecular Cancer|2020|548
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
|Journal of Experimental & Clinical Cancer Research|2021|535
A Pituitary-Derived MEG3 Isoform Functions as a Growth Suppressor in Tumor Cells
|The Journal of Clinical Endocrinology & Metabolism|2003|448